104 related articles for article (PubMed ID: 17376398)
1. Major metabolic homocysteine-derivative, homocysteine thiolactone, exerts changes in pancreatic beta-cell glucose-sensing, cellular signal transduction and integrity.
Patterson S; Flatt PR; McClenaghan NH
Arch Biochem Biophys; 2007 May; 461(2):287-93. PubMed ID: 17376398
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine and other structurally-diverse amino thiols can alter pancreatic beta cell function without evoking cellular damage.
Patterson S; Flatt PR; McClenaghan NH
Biochim Biophys Acta; 2006 Jul; 1760(7):1109-14. PubMed ID: 16632205
[TBL] [Abstract][Full Text] [Related]
3. Detrimental actions of metabolic syndrome risk factor, homocysteine, on pancreatic beta-cell glucose metabolism and insulin secretion.
Patterson S; Flatt PR; Brennan L; Newsholme P; McClenaghan NH
J Endocrinol; 2006 May; 189(2):301-10. PubMed ID: 16648297
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine-induced impairment of insulin secretion from clonal pancreatic BRIN-BD11 beta-cells is not prevented by catalase.
Patterson S; Flatt PR; McClenaghan NH
Pancreas; 2007 Jan; 34(1):144-51. PubMed ID: 17198197
[TBL] [Abstract][Full Text] [Related]
5. Prolonged exposure to homocysteine results in diminished but reversible pancreatic beta-cell responsiveness to insulinotropic agents.
Patterson S; Scullion SM; McCluskey JT; Flatt PR; McClenaghan NH
Diabetes Metab Res Rev; 2007 May; 23(4):324-34. PubMed ID: 17089371
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the role of N-methyl-D-aspartate (NMDA) receptors in insulin secreting beta-cells.
Patterson S; Irwin N; Guo-Parke H; Moffett RC; Scullion SM; Flatt PR; McClenaghan NH
Eur J Pharmacol; 2016 Jan; 771():107-13. PubMed ID: 26688567
[TBL] [Abstract][Full Text] [Related]
7. L-Alanine induces changes in metabolic and signal transduction gene expression in a clonal rat pancreatic beta-cell line and protects from pro-inflammatory cytokine-induced apoptosis.
Cunningham GA; McClenaghan NH; Flatt PR; Newsholme P
Clin Sci (Lond); 2005 Nov; 109(5):447-55. PubMed ID: 16045439
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of homocysteine toxicity to insulin-secreting BRIN-BD11 cells in combination with alloxan.
Scullion SM; Gurgul-Convey E; Elsner M; Lenzen S; Flatt PR; McClenaghan NH
J Endocrinol; 2012 Aug; 214(2):233-8. PubMed ID: 22582095
[TBL] [Abstract][Full Text] [Related]
9. Physiological regulation of the pancreatic {beta}-cell: functional insights for understanding and therapy of diabetes.
McClenaghan NH
Exp Physiol; 2007 May; 92(3):481-96. PubMed ID: 17272356
[TBL] [Abstract][Full Text] [Related]
10. Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic β-cell function and insulin secretion.
McKillop AM; Ng MT; Abdel-Wahab YH; Flatt PR
Diabetes Obes Metab; 2014 Oct; 16(10):937-46. PubMed ID: 24702738
[TBL] [Abstract][Full Text] [Related]
11. Cellular responses of novel human pancreatic β-cell line, 1.1B4 to hyperglycemia.
Vasu S; McClenaghan NH; McCluskey JT; Flatt PR
Islets; 2013; 5(4):170-7. PubMed ID: 23985558
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor agonist induced changes in clonal rat BRIN-BD11 beta-cell insulin secretion and signal transduction.
Kiely A; Robinson A; McClenaghan NH; Flatt PR; Newsholme P
J Endocrinol; 2009 Sep; 202(3):365-73. PubMed ID: 19553279
[TBL] [Abstract][Full Text] [Related]
13. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels.
Jakubowski H
FASEB J; 1999 Dec; 13(15):2277-83. PubMed ID: 10593875
[TBL] [Abstract][Full Text] [Related]
14. Acute and long-term effects of metformin on the function and insulin secretory responsiveness of clonal β-cells.
McKiney JM; Irwin N; Flatt PR; Bailey CJ; McClenaghan NH
Biol Chem; 2010 Dec; 391(12):1451-9. PubMed ID: 20868233
[TBL] [Abstract][Full Text] [Related]
15. Prolonged L-alanine exposure induces changes in metabolism, Ca(2+) handling and desensitization of insulin secretion in clonal pancreatic beta-cells.
McClenaghan NH; Scullion SM; Mion B; Hewage C; Malthouse JP; Flatt PR; Newsholme P; Brennan L
Clin Sci (Lond); 2009 Feb; 116(4):341-51. PubMed ID: 18702613
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation.
Najib S; Sánchez-Margalet V
J Mol Endocrinol; 2005 Feb; 34(1):119-26. PubMed ID: 15691882
[TBL] [Abstract][Full Text] [Related]
17. Iterative exposure of clonal BRIN-BD11 cells to ninhydrin enables selection of robust toxin-resistant cells but with decreased gene expression of insulin secretory function.
Liu HK; McCluskey JT; McClenghan NH; Flatt PR
Pancreas; 2008 Apr; 36(3):294-301. PubMed ID: 18362844
[TBL] [Abstract][Full Text] [Related]
18. Hydrolysis of homocysteine thiolactone results in the formation of Protein-Cys-S-S-homocysteinylation.
Silla Y; Varshney S; Ray A; Basak T; Zinellu A; Sabareesh V; Carru C; Sengupta S
Proteins; 2019 Aug; 87(8):625-634. PubMed ID: 30869815
[TBL] [Abstract][Full Text] [Related]
19. Actions of PGLa-AM1 and its [A14K] and [A20K] analogues and their therapeutic potential as anti-diabetic agents.
Owolabi BO; Musale V; Ojo OO; Moffett RC; McGahon MK; Curtis TM; Conlon JM; Flatt PR; Abdel-Wahab YHA
Biochimie; 2017 Jul; 138():1-12. PubMed ID: 28392407
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic analysis of pancreatic beta cells following exposure to high glucose.
Wallace M; Whelan H; Brennan L
Biochim Biophys Acta; 2013 Mar; 1830(3):2583-90. PubMed ID: 23153904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
